long term effects of glp 1 agonists Peptide/GLP-1 Complications: 11 Hidden Risks and Side You Must Know Exploring the Side Effects of
Description
Whats the difference between GLP-1 and dual agonists
NCT03861052), insulin glargine (ClinicalTrials.gov registration no

The appropriate statistical test was done and indicated in the chart below for each individual experiment

In the semaglutide group, there was an improvement in quality of life according to the Kansas City Cardiomyopathy Questionnaire (KCCQ-CSS), with a mean change in KCCQ-CSS score of 13.7 points with semaglutide and 6.4 points with placebo (p 1% significantly decreased hospitalisations (aOR 1.33

GLP-1 RAs promote weight loss [41], hence our findings of an increase in weight with GLP-1 RA therapy at 5 years was interesting

Their proposed mechanisms include: Reducing neuroinflammation: They can decrease inflammation in the brain, which is a factor in neurodegenerative diseases [19, 20]
